Related Experiment Video

Updated: May 12, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

Synuclein-γ suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells

Bo Liang1, Xin-Jun Wang, Pei-Hong Shen

  • 1Departments of Neurosurgery, Zhengzhou, Henan 450052, P.R. China ;

Oncology Letters
|April 20, 2013
PubMed

Insights

Downregulating synuclein-gamma (SNCG) using RNA interference (RNAi) significantly reduced the growth and spread of MCF-7 breast cancer cells. This suggests RNAi targeting SNCG may offer a new treatment for advanced breast cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Synuclein-gamma (SNCG) is implicated in cancer progression.
  • Understanding SNCG's role in breast cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of synuclein-gamma (SNCG) downregulation via RNA interference (RNAi) on MCF-7 breast cancer cell clonogenicity and invasiveness.
  • To evaluate the efficacy of SNCG-specific siRNAs in suppressing gene expression.

Main Methods:

  • Utilized four pairs of synuclein-gamma (SNCG)-specific siRNAs cloned into the pGPU6 plasmid for transfection into MCF-7 cells.
  • Assessed SNCG knockdown efficiency using reverse transcription polymerase chain reaction (RT-PCR) and immunocytochemistry.
  • Evaluated cell clonogenicity and invasiveness through clonogenic and Boyden chamber assays.

Main Results:

  • All four SNCG siRNAs significantly inhibited SNCG expression at both mRNA and protein levels compared to controls (P<0.001).
  • RNA interference-mediated SNCG suppression markedly reduced MCF-7 cell clonogenicity (P=0.002) and invasiveness (P<0.001).

Conclusions:

  • RNA interference effectively suppresses synuclein-gamma (SNCG) expression in breast cancer cells.
  • SNCG suppression via RNAi demonstrates potential as a novel therapeutic strategy for advanced breast cancer.
Keywords:
MCF-7 cell lineRNA interferencebreast cancersynuclein-γ

More Related Videos

Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay19:34

Cellular Toxicity of Nanogenomedicine in MCF-7 Cell Line: MTT assay

Published on: April 3, 2009

A Method to Study &#945;-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...